These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29977345)

  • 1. Tigecycline application in a 3-month-old infant with multiple drug resistant
    Peng C; Wang X; Zhang J; Jiang Y; Hou X
    Gut Pathog; 2018; 10():25. PubMed ID: 29977345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experience with tigecycline compassionate use in pediatric patients infected with carbapenem resistant Klebsiella pneumoniae].
    Hurtado IC; Trujillo M; Restrepo A; Garcés C; Tamayo C; Mesa JG
    Rev Chilena Infectol; 2012 Jun; 29(3):317-21. PubMed ID: 23096472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Donor-derived Carbapenem-resistant Klebsiella pneumoniae Infection after Renal Transplantation with Tigecycline and Extended-infusion Meropenem.
    Wang ZQ; Guo ZL; Feng H; Fu C; Zhao GY; Ma K; Zhu L; Chen G
    Curr Med Sci; 2021 Aug; 41(4):770-776. PubMed ID: 34403102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant
    Van der Weide H; Ten Kate MT; Vermeulen-de Jongh DMC; Van der Meijden A; Wijma RA; Boers SA; Van Westreenen M; Hays JP; Goessens WHF; Bakker-Woudenberg IAJM
    Antibiotics (Basel); 2020 Mar; 9(3):. PubMed ID: 32138210
    [No Abstract]   [Full Text] [Related]  

  • 5. [The efficacy and safety of different antimicrobial regimens in carbapenem-resistant
    Sun WM; Zhou H; Shen LS; Yang Q; Ma WJ; Zhou JY
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):566-571. PubMed ID: 31365977
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria.
    Iosifidis E; Violaki A; Michalopoulou E; Volakli E; Diamanti E; Koliouskas D; Antachopoulos C; Drossou-Agakidou V; Sdougka M; Roilides E
    J Pediatric Infect Dis Soc; 2017 Jun; 6(2):123-128. PubMed ID: 27000866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline Therapy in an Infant for Ventriculoperitoneal Shunt Meningitis.
    Emiroglu M; Alkan G; Turk Dagi H
    Pediatrics; 2017 Jan; 139(1):. PubMed ID: 27974589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.
    Chen F; Shen C; Pang X; Zhang Z; Deng Y; Han L; Chen X; Zhang J; Xia Q; Qian Y
    Transpl Infect Dis; 2020 Feb; 22(1):e13199. PubMed ID: 31627248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline-induced sustained severe hypoglycemia: a case report.
    Chen Y; Li L; Zhang N; Li H
    BMC Pharmacol Toxicol; 2019 Aug; 20(1):50. PubMed ID: 31426870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment.
    He F; Shi Q; Fu Y; Xu J; Yu Y; Du X
    Infect Genet Evol; 2018 Dec; 66():188-191. PubMed ID: 30268919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline Therapy for Multi-drug-Resistant
    Krasnanova V; Kovacikova L
    SN Compr Clin Med; 2020; 2(8):1248-1250. PubMed ID: 32838166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies.
    Lin S; Zhang C; Ye S
    Int J Clin Pharm; 2018 Oct; 40(5):1030-1036. PubMed ID: 30051224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study.
    Geng TT; Xu X; Huang M
    Medicine (Baltimore); 2018 Feb; 97(8):e9961. PubMed ID: 29465589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report.
    Wu Y; Chen K; Zhao J; Wang Q; Zhou J
    J Chemother; 2018 Feb; 30(1):49-52. PubMed ID: 28614982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.
    Balandin Moreno B; Fernández Simón I; Pintado García V; Sánchez Romero I; Isidoro Fernández B; Romera Ortega MA; Alcántara Carmona S; Pérez Redondo M; Galdos Anuncibay P
    Scand J Infect Dis; 2014 Mar; 46(3):175-80. PubMed ID: 24354959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term, low-dose tigecycline to treat relapsing bloodstream infection due to KPC-producing Klebsiella pneumoniae after major hepatic surgery.
    Morelli L; Tartaglia D; Furbetta N; Palmeri M; Ferranti S; Tagliaferri E; Di Candio G; Mosca F
    Int J Infect Dis; 2015 Jul; 36():4-5. PubMed ID: 25975648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance evolution of hypervirulent carbapenem-resistant
    Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
    Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.